Development of a risk score model for 1-year graft loss after adult deceased donor liver transplantation in Japan based on a 20-year nationwide cohort.

Japan brain death database liver transplantation risk assessment

Journal

Annals of gastroenterological surgery
ISSN: 2475-0328
Titre abrégé: Ann Gastroenterol Surg
Pays: Japan
ID NLM: 101718062

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 30 11 2021
revised: 10 03 2022
accepted: 25 03 2022
entrez: 12 9 2022
pubmed: 13 9 2022
medline: 13 9 2022
Statut: epublish

Résumé

Using nationwide data collected over the past 20 years, we aimed to investigate deceased donor liver transplantation (DDLT) outcomes to develop a unique risk model that can be used to establish a standard for organ acceptance in Japan. Data were collected for 449 recipients aged ≥18 years who underwent DDLT between 1999 and 2019. Least absolute shrinkage and selection operator (LASSO) regression analysis was utilized to develop an original risk score model for 1-year graft loss (termed the Japan Risk Index [JRI]). We developed risk indices according to recipient, donor, and surgery components (termed JRI-R, D, and S, respectively). The JRI was validated via a 5-fold cross-validation. We also compared DDLT outcomes and risk indices among Era1 (-2011), Era2 (-2015), and Era3 (-2019). The 1-year graft survival rate was 89.5% and improved significantly, reaching 84.7%, 87.6%, and 93.9% in Era1, Era2, and Era3, respectively. The JRI was calculated as JRI-R (re-transplantation, Model for End-Stage Liver Disease score, medical condition in intensive care unit) × JRI-D (age, catecholamine index, maximum sodium, maximum total bilirubin) × JRI-S (total ischemic time) × 0.84. The risk model achieved a mean C-statistic value of 0.81 in the validation analysis. The risk index was significantly lower in Era3 than in Era2. Changes in the risk index over time indicated that avoiding risks contributed to the improved outcomes in Era3. The JRI is unique to adult DDLT in Japan and may be useful as a reference for organ acceptance in the future.

Identifiants

pubmed: 36091314
doi: 10.1002/ags3.12573
pii: AGS312573
pmc: PMC9444863
doi:

Types de publication

Journal Article

Langues

eng

Pagination

712-725

Informations de copyright

© 2022 The Authors. Annals of Gastroenterological Surgery published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Gastroenterology.

Déclaration de conflit d'intérêts

Author YK is Editor in Chief of Annals of Gastroenterological Surgery. Author HO and SE are current editors of Annals of Gastroenterological Surgery.

Références

Ann Surg. 2019 Aug;270(2):333-339
pubmed: 29958229
Ann Surg. 2006 Jun;243(6):748-53; discussion 753-5
pubmed: 16772778
Hepatol Res. 2011 Sep;41(9):805-12
pubmed: 21884340
Am J Transplant. 2006 Apr;6(4):783-90
pubmed: 16539636
Am J Transplant. 2008 Jun;8(6):1186-96
pubmed: 18522546
Transplantation. 2005 May 27;79(10):1445-52
pubmed: 15912118
Pediatr Transplant. 2019 Dec;23(8):e13578
pubmed: 31535772
Ther Apher Dial. 2015 Aug;19(4):316-23
pubmed: 26386218
Bioinformatics. 2005 Oct 15;21(20):3940-1
pubmed: 16096348
Transplantation. 2019 Oct;103(10):e297-e307
pubmed: 31283673
Br J Surg. 1973 Aug;60(8):646-9
pubmed: 4541913
Clin Transplant. 2018 Mar;32(3):e13187
pubmed: 29314293
Am J Kidney Dis. 2009 Jun;53(6):982-92
pubmed: 19339088
Am J Transplant. 2012 Oct;12(10):2789-96
pubmed: 22823098
J Thorac Cardiovasc Surg. 2021 May 11;:
pubmed: 34112503
Transplantation. 2019 Jan;103(1):78-90
pubmed: 30418431
Transplant Proc. 2013 May;45(4):1327-30
pubmed: 23726564
Liver Transpl. 2010 Dec;16(12):1393-9
pubmed: 21117249
Transplant Proc. 2012 Mar;44(2):373-5
pubmed: 22410020
J Hepatobiliary Pancreat Sci. 2021 Nov;28(11):1014-1022
pubmed: 33315309
Transplantation. 2017 Apr;101(4):786-792
pubmed: 27906826
Am J Transplant. 2008 Dec;8(12):2537-46
pubmed: 18945283
J Hepatobiliary Pancreat Sci. 2015 Dec;22(12):837-45
pubmed: 26485678
J Gastroenterol Hepatol. 2012 Mar;27(3):540-6
pubmed: 21777274
Ann Surg. 2012 Nov;256(5):861-8; discussion 868-9
pubmed: 23095632
Am J Transplant. 2009 Feb;9(2):318-26
pubmed: 19120079
Sci Rep. 2018 Jun 29;8(1):9871
pubmed: 29959344

Auteurs

Yusuke Takemura (Y)

Department of Surgery Keio University School of Medicine Tokyo Japan.

Masahiro Shinoda (M)

Digestive Disease Center Mita Hospital International University of Health and Welfare Tokyo Japan.

Ryo Takemura (R)

Biostatistics Unit, Clinical and Translational Research Center Keio University School of Medicine Tokyo Japan.

Yasushi Hasegawa (Y)

Department of Surgery Keio University School of Medicine Tokyo Japan.

Yohei Yamada (Y)

Department of Surgery Keio University School of Medicine Tokyo Japan.

Hideaki Obara (H)

Department of Surgery Keio University School of Medicine Tokyo Japan.

Minoru Kitago (M)

Department of Surgery Keio University School of Medicine Tokyo Japan.

Seisuke Sakamoto (S)

Organ Transplantation Center National Center for Child Health and Development Tokyo Japan.

Mureo Kasahara (M)

Organ Transplantation Center National Center for Child Health and Development Tokyo Japan.

Koji Umeshita (K)

Division of Health Science Osaka University Graduate School of Medicine Osaka Japan.

Susumu Eguchi (S)

Department of Surgery Nagasaki University Graduate School of Biomedical Science Nagasaki Japan.

Hideki Ohdan (H)

Department of Gastroenterological and Transplant Surgery Hiroshima University Graduate School of Biomedical and Health Sciences Hiroshima Japan.

Hiroto Egawa (H)

Department of Surgery Institute of Gastroenterology Tokyo Women's Medical University Tokyo Japan.

Yuko Kitagawa (Y)

Department of Surgery Keio University School of Medicine Tokyo Japan.

Classifications MeSH